Special Issues
Table of Content

Targeting Inflammatory Diseases with Novel Strategies: Cellular and Molecular Mechanisms

Submission Deadline: 30 April 2026 View: 462 Submit to Special Issue

Guest Editors

Dr. Srinivasa Reddy Bonam

Email: bsrpharmacy90@gmail.com

Affiliation: Vaccine Immunology Laboratory, Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, 500007, Hyderabad, India

Homepage:

Research Interests: inflammatory diseases, drug discovery, cell-based therapies, molecular mechanisms, humanized mouse models, and autophagy

图片1.png


Dr. Magali Humbert

Email: magali.humbert@yahoo.fr

Affiliation: HemostOD SA, EPFL Innovation Park, 1025 St Sulpice, VD, Switzerland

Homepage:

Research Interests: leukemia, platelets, megakaryocytes, autophagy, and differentiation therapy

图片2.png


Summary

Inflammatory diseases encompass a broad range of disorders characterized by dysregulated immune responses and persistent tissue inflammation. While progress has been made in therapeutic interventions, many inflammatory conditions remain difficult to treat due to their complex pathogenesis at the cellular and molecular levels.

This special issue of BIOCELL aims to bring together cutting-edge research that explores novel strategies to target inflammatory diseases, with a specific emphasis on cellular processes and intracellular regulatory mechanisms such as autophagy, cell death pathways, and organelle stress responses.

We invite contributions that unravel how autophagy and related cellular systems participate in the initiation, amplification, or resolution of inflammation. Manuscripts addressing how these mechanisms are harnessed or modulated by innovative therapeutic approaches—ranging from small molecules and biologics to genetic and nanomedicine-based strategies—are particularly encouraged.

Topics of Interest (include but are not limited to):
· Role of autophagy in innate and adaptive immune responses during inflammation
· Crosstalk between autophagy and inflammatory signaling (e.g., NF-κB, NLRP3 inflammasome)
· Autophagy as a therapeutic target in autoimmune or chronic inflammatory diseases
· Novel anti-inflammatory agents modulating autophagic flux
· Interplay between autophagy, apoptosis, pyroptosis, and other cell stress responses
· Intracellular trafficking, lysosomal dynamics, and organelle communication in inflammation
· Nanotechnology and gene therapy tools targeting cellular homeostasis pathways
· Animal and 3D models for studying autophagy-inflammation interactions


Keywords

inflammatory diseases, autophagy, cellular signaling pathways, immune regulation, molecular mechanisms, therapeutic targets, cell stress responses, innate and adaptive immunity

Published Papers


  • Open Access

    ARTICLE

    METTL3-Mediated m6A Regulation of PTEN Promotes Macrophage Ferroptosis in Gouty Arthritis

    Gang Yang, Xiongwu Long, Xingchang Fu
    BIOCELL, DOI:10.32604/biocell.2026.075362
    (This article belongs to the Special Issue: Targeting Inflammatory Diseases with Novel Strategies: Cellular and Molecular Mechanisms)
    Abstract Objectives: Macrophage ferroptosis is linked to the pathogenesis of gouty arthritis (GA), yet the precise regulatory mechanism needs to be elucidated. This study aimed to investigate the role of macrophage ferroptosis in GA and its potential mechanisms. Methods: THP-1 macrophages were stimulated with monosodium urate (MSU) crystals to simulate the GA model. The co-culture system of macrophages and primary chondrocytes (hCDs) was employed to analyze the effects of macrophage-mediated inflammation on chondrocyte degeneration. Results: MSU stimulation induced ferroptosis in macrophages, accompanied by increased methyltransferase-like 3 (METTL3) expression (p = 0.003) and total m6A modification level (p = 0.0058).… More >

Share Link